Cancer Control
This program studies how behavioral, clinical, environmental, and social factors influence cancer risk, treatment, and survivorship. Researchers use clinical data and population-based approaches to identify gaps in care, define drivers of disparities, and develop interventions that improve screening, access, and outcomes across the cancer continuum.
Cancer Biology
This program investigates how tumors arise, evolve, and resist therapy by defining the biological mechanisms that drive cancer at the molecular, cellular, and system levels. Investigators identify disease dependencies, map vulnerabilities in cancer cells, and uncover targets and pathways that can be advanced toward new therapeutic strategies.
Discovery and Developmental Therapeutics
This program advances new cancer therapies from discovery through preclinical development and early-phase clinical testing. Investigators identify and validate therapeutic targets, develop novel agents and combinations, and translate promising findings into investigator-initiated and first-in-human clinical trials.
Integrated Disease-Oriented Teams
Research programs are further enhanced by 16 integrated Disease-Oriented Teams (iDOTs) comprised of basic, translational, clinical, and population health scientists focused on specific disease areas. Through multi-disciplinary collaboration, these teams hold the shared goal of translating discoveries into new treatments and therapies.
